Streetbeat News

Stock Prices

MSFT

Microsoft reported strong Q4 earnings with revenue and EPS beating estimates. Cloud revenue grew 21% YoY, but Azure growth missed expectations, causing a drop in after-hours trading. The company returned $8.4 billion to shareholders and highlighted its focus on AI leadership.

Portfolio Pulse from Chris Katje

July 30, 2024 | 8:24 pm

UMBF

UMB Financial (NASDAQ:UMBF) reported Q2 2024 adjusted EPS of $2.16, beating the estimate of $2.01. Sales were $390.027M, surpassing the $384.937M estimate and showing a 7.24% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:24 pm

MDLZ

Mondelēz International has announced an 11% increase in its quarterly dividend, raising it from $0.425 to $0.47 per share. The dividend will be payable on October 14, 2024, to shareholders of record as of September 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:22 pm

BHE

Benchmark Electronics (BHE) has provided its Q3 2024 revenue guidance in the range of $630M-$670M, compared to the $635M estimate. The company also expects adjusted EPS to be between $0.52-$0.58, versus the $0.51 estimate.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:22 pm

TECX

Tectonic Therapeutic, Inc. (NASDAQ: TECX) has received FDA clearance for its Investigational New Drug (IND) application for TX45, an Fc-relaxin fusion protein aimed at treating Group 2 Pulmonary Hypertension due to Heart Failure with Preserved Ejection Fraction (PH-HFpEF). The company plans to initiate a global Phase 2 clinical trial in Q3 2024, with topline results expected in 2026. Phase 1a results in healthy volunteers are expected this September, and Phase 1b results in mid-2025.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:22 pm

AAPL

AFRM

AMZN

SHOP

Affirm Holdings Inc (NASDAQ:AFRM) received an upgrade from B of A Securities analyst Jason Kupferberg, who raised the stock from Neutral to Buy with a price target of $36. The analyst cited potential GAAP profitability, lower interest rates, and strong partnerships with Apple and Amazon as key factors. The fourth-quarter results and fiscal 2025 forecasts are expected to be positive catalysts.

Portfolio Pulse from Anusuya Lahiri

July 30, 2024 | 8:21 pm

TEX

Terex Corporation has announced its FY24 adjusted EPS guidance to be in the range of $7.15 to $7.45, surpassing the previous estimate of $7.02.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:21 pm

KRG

Kite Realty Group (KRG) has updated its FY24 NAREIT FFO guidance to a range of $2.04-$2.08, slightly narrowing the previous range of $2.02-$2.08.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:21 pm

MGNX

MacroGenics provided an update on its Vobramitamab Duocarmazine (vobra duo) program, including the TAMARACK study. The study reached its primary endpoint, leading to the discontinuation of additional dosing for remaining participants. The company plans to present data at the ESMO Congress 2024 and expects to have mature efficacy findings later in the year.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:20 pm

AMD

AMD shares are trading higher following better-than-expected Q2 earnings.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:20 pm